The Viability of Emerging Public and Private Generic Drug Infrastructure in India: An in-vitro Case Study Using Statins as Model Drug
Article Sidebar
Main Article Content
Abstract
The healthcare system has been fundamentally altered by the introduction of generic medications, and their market share continues to rise because these are genuine, dependable, secure, affordable, and accessible to all the needy and poor in society. In this regard, the generic drug industry, which strives for authenticity, affordability, and accessibility, plays a significant role. Using HMG CoA reductase inhibitors (Atorvastatin and Rosuvastatin) as model drugs, the study aimed to determine the viability of the emerging public and private generic drug infrastructure in India, which included Janaushadhi, Dava India, and other assorted companies. The organoleptic properties and official and non-official quality control tests were evaluated. According to the in-vitro dissolution profiles, the Mankind brand of atorvastatin has shown the highest dissolution profile (75.29%), and the Dava India brand of rosuvastatin has the maximum drug release (97.26%) in one hour release. The Peppas model best explained the drug release model, which inferred the release profile to be diffusion-specific. The compatibility analysis of the tablet formulation has been shown through FTIR studies. These results concluded that public generic drugs are as effective as private generic drugs, and patients can easily take the cost-effective brand of medication.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
Mishra, R., & Sathyaseelan, B. (2019, January 2). Generic Drug Distribution in India- Issues and Challenges. Journal of Pharmaceutical Care & Health Systems, 06(01), 199. https://doi.org/10.4172/2376-0419.1000199
Mahato, T., & Raulji, D. (2021, August 16). Present scenario of generic medicines in India: A comparative study. World Journal of Biology Pharmacy and Health Sciences, 7, 053-059. https://doi.org/ 10.30574/wjbphs.2021.7.2.0086
Dixit, A., Kumar, N., Kumar, S. (2019, January 1). Use of Generic Medicines: Challenges and Benefits. Journal of Health Management, 20(1), 1-7. https://doi.org/ 10.1177/0972063417747747
Junofy, A.R. (2013, September). A Study on Poverty and Hunger in India. Mediterranean Journal of Social Sciences, 4(12), 147-153. https://doi.org/ 10.5901/mjss.2013.v4n12p147
Mukherjee, K. (2017, May 1). A Cost Analysis of the Jan Aushadhi Scheme in India. International Journal Health Policy Management, 6(5), 253-256. https://doi.org/ 10.15171/ijhpm.2017.02
Lennernas, H., Fager, G. (1997). Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors: similarities and differences. Clin Pharmacokinet, 32(5), 403–425. https://doi.org/ 10.2165/00003088-199732050-00005
Illingworth, D., Tobert, J. (2001, February). HMG-CoA reductase inhibitors. Advances in protein chemistry, 56, 77-114. https://doi.org/10.1016/S0065-3233(01)56003-9
Balasubramanian, R., Maideen. N. (2021). HMG-CoA Reductase Inhibitors (Statins) and their Drug Interactions Involving CYP Enzymes, P-glycoprotein and OATP Transporters-An Overview. Curr Drug Metab, 22(5), 328-341. https://doi.org/ 10.2174/1389200222666210114122729
Endo, A., Hasumi, K. (1994). HMG-CoA reductase inhibitors. Natural product reports, 10, 541-50. https://doi.org/10.1039/NP9931000541
Mukundan, D., Vasanthakumari, R. (2014). Basic analytical parameters of Atorvastatin Calcium IP (Atroveen-10) granular, compressed, and film-coated tablets. Journal of Biochemical Sciences, 1(1), 39-49.
Kogawa, A., Pires, A., Salgado, H. (2019, May 1). Atorvastatin: A Review of Analytical Methods for Pharmaceutical Quality Control and Monitoring. Journal of AOAC International, 102(3), 801-809. https://doi.org/10.5740/jaoacint.18-0200
Kundo, N., Dutta, S., Sarker, A., Sultana, C., Haque, M.A., Islam, M.N. (2016). Formulation and Evaluation of Rosuvastatin Immediate Release Tablets 10 Mg. IOSR Journal of Pharmacy and Biological Sciences, 11(05), 01-05. https://doi.org/ 10.9790/3008-1105030105
Lamb, Y. (2020, August). Rosuvastatin/Ezetimibe: A Review in Hypercholesterolemia. A Journal of Cardiovasc Drugs, 20(4), 381-392. https://doi.org/10.1007/s40256-020-00421-1
Parikh, B., Patel, D., Patel, C., Dave, J., Gothi, G., Patel, T. (2010, February). Formulation, optimization, and evaluation of immediate release tablet of telmisartan. Journal of Global Pharma Technology, 2(2), 79-84.
Ramu, B., Manasa, M.S. (2015). Formulation and Evaluation of Colon Specific Drug Delivery of Press Coated Lansoprazole Tablets. Indo American Journal of Pharmaceutical Research, 5(4),1522.
Tanni, A., Tabassum, S., Mahmud, R., Idris, J., Shahriar, M. (2017). Comparative in vitro analysis of physicochemical properties of some aceclofenac generic tablets marketed in Bangladesh. Journal of Biomedical and Pharmaceutical Research, 6(3), 99-105.
Desu, P., Rao, P., Prasanthi, T., Lakshmi, G., Sankar, K., Muneer, S. (2018). Formulation and Evaluation of Immediate Release Tablets of Nevirapine Solid Dispersions. ARC Journal of Pharmaceutical Sciences, 4(3), 13-20. https://doi.org/ 10.20431/2455-1538.0404001
Chavan, H., Chhabra, G., Gujarathi, N., Jadhav, A. (2018, July). Comparative study of In-process and finished products quality control test for tablet and capsules according to pharmacopeias. Asian Journal of Pharmaceutical Research and Development. 6(3), 60-68. https://doi.org/10.22270/ajprd.v6i3.370
Saleem, M., Shahin, M., Srinivas, B., Begum, A. (2014). Evaluation of tablets by friability apparatus. International Journal of Research in Pharmacy and Chemistry, 4(4),837-840.
Maclean, N., Walsh, E., Soundaranathan, M., Khadra, I., Mann, J., Williams, H., Markl, D. (2021, April). Exploring the performance-controlling tablet disintegration mechanisms for direct compression formulations. International Journal of Pharmacy, 599,120221. https://doi.org/ 10.1016/j.ijpharm.2021.120221
Bozal-Palabiyik, B., Uslu, B., Ozkan, Y., Ozkan, S. (2018). In-Vitro Drug Dissolution Studies in Medicinal Compounds. Curr Med Chem. 25(33),4020-4036. https://doi.org/ 10.2174/0929867325666180322145335.
Mohapatra, S., Sahoo, R., Mallick, S., Mohapatra, R. (2021). Enteric Dissolution Enhancement of Engineered Gastro Resistant Omeprazole Tablets using Hydroxypropyl Methylcellulose Acetate Succinate. Indian Journal of Pharmaceutical Education and Research, 55(3), 677-684. https://doi.org/ 10.5530/ijper.55.3.139
Kumar, N., Nath, G. (2013, September). Xanthan gum based once a day matrix tablet of cefixime trihydrate: development and evaluation. International Journal of Pharmaceutical Sciences and Research, 4(9), 3390-3399. http://dx.doi.org/10.13040/IJPSR.0975-8232.4(9).3390-99
Berthomieu, C., Hienerwadel, R. (2009, August). Fourier transform infrared (FTIR) spectroscopy. Photosynth Res, 101(2-3),157-70. https://doi.org/10.1007/s11120-009-9439-x
Noor, S., Salam, F.B., Hima, H.N., Bhuiyan, S., Chowdhury, S. (2017, June). Comparative in-vitro quality evaluation of some brands of metronidazole tablets available in Bangladesh. International Journal of Applied Research and Studies, 3(7),753-758.
Dash, S., Murthy, P., Nath, L., Chowdhury, P. (2010, May). Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm.,67(3):217-23.
Nanjwade, V., Manvi, F., Nanjwade, B. (2013, March). Formulation and Evaluation of Dispersible Tablets of Lomefloxacin HCl. International Journal of Drug Development and Research, 5(1), 103-113.
Gopalkrishnan, Dr. S., Aggarwal, P., & Balabhadra, N. (2019). Developing Synergies in the Pharmaceutical Sector: M&A Activity post 2005. In International Journal of Recent Technology and Engineering (IJRTE) (Vol. 8, Issue 2, pp. 3256–3265). https://doi.org/10.35940/ijrte.b1651.078219
Sabitha, B., Akila, K., Radhakrishnan, G. A. A., Krishnan, G. A., & Naveen, S. (2019). Automatic Medicine Vending Machine. In International Journal of Engineering and Advanced Technology (Vol. 9, Issue 2, pp. 1850–1853). https://doi.org/10.35940/ijeat.f7977.129219
A Research on Employee Involvement in Pharmaceutical Industry in India. (2019). In International Journal of Innovative Technology and Exploring Engineering (Vol. 8, Issue 6S4, pp. 420–423). https://doi.org/10.35940/ijitee.f1085.0486s419